A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma
Titel:
A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma
Auteur:
Jonasch, E. Hasanov, E. Corn, P.G. Moss, T. Shaw, K.R. Stovall, S. Marcott, V. Gan, B. Bird, S. Wang, X. Do, K.A. Altamirano, P.F. Zurita, A.J. Doyle, L.A. Lara Jr, P.N. Tannir, N.M.